By Professor Susan Jane Connor

Book Chapters

Connor S; Wu Y, 2024, 'WHAT ARE THE RISKS OF BIOLOGIC THERAPIES AND HOW DO YOU COMMUNICATE THEM TO PATIENTS?', in Curbside Consultation in IBD: 49 Clinical Questions, pp. 115 - 121, http://dx.doi.org/10.1201/9781003523567-23

Journal articles

De Gregorio M; Winata LS; Hartley I; Behrenbruch CC; Connor SJ; D'Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJS; Schulberg JD; Srinivasan A; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2025, 'A new protocolised treatment strategy optimising medical and surgical care leads to improved healing of Crohn's perianal fistulas.', J Crohns Colitis, http://dx.doi.org/10.1093/ecco-jcc/jjae199

Karimi N; Moore AR; Jones A; Lukin A; Pipicella JL; Williams AJ; Ng W; Kanazaki R; Kariyawasam V; Mitrev N; Pandya K; Andrews JM; Connor SJ, 2025, 'On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease', Patient Education and Counseling, 130, http://dx.doi.org/10.1016/j.pec.2024.108487

Cosier D; Lambert K; Charlton K; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg DA; Houshyar Y; Jayawardana T; Koentgen S; Hold GL, 2024, 'Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis †', Nutrients, 16, http://dx.doi.org/10.3390/nu16244349

Kanazaki R; Smith B; Bu S; Girgis A; Connor SJ, 2024, 'Is the European Crohn’s and Colitis organisation (ECCO) e-guide an acceptable and feasible tool for increasing gastroenterologists’ guideline adherence? A mixed methods evaluation', BMC Medical Education, 24, http://dx.doi.org/10.1186/s12909-024-05540-w

Jacob R; Chu V; Ng W; Williams AJ; Connor S, 2024, 'Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience', Internal Medicine Journal, 54, pp. 2009 - 2014, http://dx.doi.org/10.1111/imj.16545

Akyüz F; An YK; Begun J; Aniwan S; Bui HH; Chan W; Choi CH; Chopdat N; Connor SJ; Desai D; Flanagan E; Kobayashi T; Lai AY-H; Leong RW; Leow AH-R; Leung WK; Limsrivilai J; Muzellina VN; Peddi K; Ran Z; Wei SC; Sollano J; Teo MMH; Wu K; Ye BD; Ooi CJ, 2024, 'Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition.', Intest Res, http://dx.doi.org/10.5217/ir.2024.00089

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Lan-San Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2024, 'Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial', Clinical Gastroenterology and Hepatology, 22, pp. 2299 - 2308.e5, http://dx.doi.org/10.1016/j.cgh.2024.04.019

Katsoudas N; Tavakoli P; Wu N; Shapiro A; Leach ST; Williams AJ; Paramsothy R; Ghaly S; Connor SJ; Samocha-Bonet D; Lambert K; Hold GL, 2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250, http://dx.doi.org/10.1093/ibd/izad318

Little RD; McKenzie J; Srinivasan A; Hilley P; Gilmore RB; Chee D; Sandhu M; Saitta D; Chow E; Thin L; Walker GJ; Moore GT; Lynch K; Andrews J; An YK; Bryant RV; Connor SJ; Garg M; Wright EK; Hold G; Segal JP; Boussioutas A; De Cruz P; Ward MG; Sparrow MP, 2024, 'Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081787

De Gregorio M; Sidhu A; Behrenbruch C; Connor SJ; Guerra G; Johnston MJ; Keck JO; Ong EJSK; Thompson AJ; Woods R; D'Souza B; Ding NS, 2024, 'Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand', ANZ Journal of Surgery, 94, pp. 14 - 16, http://dx.doi.org/10.1111/ans.18640

Alshiwanna B; Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1818 - i1818, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1135

Barnett M; Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1829 - i1829, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1142

Pipicella JL; Wilson W; Ghaly S; Antoniades S; Kate L; Grafton R; Ng W; Sechi A; Somes K; Arnold K; Connor SJ; Andrews JM, 2024, 'P1030 Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1858 - i1859, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1160

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i2023 - i2023, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1259

Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i657 - i657, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0416

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i930 - i930, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0592

Pipicella JL; Gu B; Palmer L; Connor SJ; Wilson W; Andrews JM, 2024, 'P529 Assessing patient-perceived burden of disease in Crohn’s disease: a novel scoring approach in a real-world Australasian cohort', Journal of Crohn's and Colitis, 18, pp. i1042 - i1044, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0659

De Gregorio M; Winata LS; Hartley I; Behrenbruch CC; Connor SJ; D‘Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJS; Schulberg JD; Srinivasan A; Sutherland T; Woods RJ; Wright EK; Connell WR; Thompson AJ; Ding NS, 2024, 'P547 Improved clinical and radiologic healing of Crohn’s perianal fistulas using a novel coordinated care model optimising medical and surgical treatments: A prospective real-world observational study', Journal of Crohn's and Colitis, 18, pp. i1077 - i1078, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0677

Gu B; Pipicella JL; Palmer L; Connor SJ; Wilson W; Andrews JM, 2024, 'P654 Assessing patient-perceived burden of disease in Ulcerative Colitis: a novel scoring approach in a real-world Australasian cohort', Journal of Crohn's and Colitis, 18, pp. i1246 - i1248, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0784

Khoo E; Amiss A; Ding JN; Bryant R; Mohsen W; Connor S; Leung R; Croft A; Lynch K; Sparrow M; De Cruz P; An YK; Holtmann G; Begun J, 2024, 'P854 Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis', Journal of Crohn's and Colitis, 18, pp. i1583 - i1583, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0984

Pipicella JL; McNamara J; Wilson W; Lynch K; Walker G; Begun J; Lawrance I; Ghaly S; Radford-Smith G; Williams AJ; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1622 - i1623, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1010

Pipicella JL; Dutt S; Giles E; Day AS; Wright R; Goodfellow T; William W; Andrews JM; Connor SJ, 2024, 'P940 A glance into paediatric Inflammatory Bowel Disease in Australasia – Crohn’s Colitis Cure (CCC) data insights program', Journal of Crohn's and Colitis, 18, pp. i1711 - i1712, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1070

Mcnamara J; Alshiwanna B; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JA; Connor SJ, 2024, 'P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1742 - i1742, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1089

Little RD; Jayawardana T; Koentgen S; Zhang F; Connor SJ; Boussioutas A; Ward MG; Gibson PR; Sparrow MP; Hold GL, 2024, 'Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: Advances and future directions', eGastroenterology, 2, http://dx.doi.org/10.1136/egastro-2023-100006

Pierre N; Huynh-Thu VA; Baiwir D; Mazzucchelli G; Fléron M; Trzpiot L; Eppe G; De Pauw E; Laharie D; Satsangi J; Bossuyt P; Vuitton L; Vieujean S; Colombel JF; Meuwis MA; Louis E; Dupas JL; Laharie D; Reimund JM; Bouhnik Y; Jouet P; De Vos M; Belaiche J; Vernier-Massouille G; Nancey S; Grimaud JC; Veyrac M; Boureille A; Flamant M; Jian R; Marteau P; Lemann M; Allez M; Savoye G; Duclos B; Picon L; Andrews A; Sparrow M; Leong R; Connor S; Radforth-Smith G; De Cruz P; Baert F; Louis E; Bossuyt P; Resche-Rignon M; Ding N; Almer S; Ben-Horin S; Siegmund B; Preiss J; Stallmach A; Liceni T; Grip O; Halfvarson J; Durai D; Cummings F; Seilinger C; Parkes M; Lindsay J; Lambrecht G; VanHootegem P; Rahier JF; Dewitte M; Hebuterne X; Chanteloup E; Altwegg R; Nancey S; Bouguen G; de Chambrun GP; Pollenot F; Nachury M; Laharie D; Fumery M; Picon L; Gilletta C; Viennot S; Roblin X; Satsangi J; Irving P; Lamb C; Pollok R; D'Haens G; Hertervig E; Halfvarsson J, 2024, 'External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn’s disease stopping infliximab', Gut, http://dx.doi.org/10.1136/gutjnl-2024-332648

Khoo E; Amiss A; Ding NS; Bryant RV; Mohsen W; Connor SJ; Leong R; Croft A; Lynch KD; Sparrow M; De Cruz P; An Y-K; Holtmann GJ; Begun J, 2024, '903 TOFACITINIB DEMONSTRATES PRELIMINARY EFFICACY IN INDUCTION OF REMISSION IN CHRONIC POUCHITIS', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)00988-0

McNamara J; Wilson W; Pipicella JL; Ghaly S; Begun J; Lawrance IC; Gearry R; Andrews JM; Connor SJ, 2024, 'Epidemiology and Treatment Patterns of Fistulising Crohn’s Disease in a large, real-world Australasian cohort', Gastro Hep Advances, pp. 100594 - 100594, http://dx.doi.org/10.1016/j.gastha.2024.100594

Lim E; Thai M; An Y-K; Hendy P; Alchlaihawi M; Leong R; Connor S; Ng W; Gu B; Thin L; Sparrow M; Gilmore R; Taylor K; Sallis O; Andrews JM; Daker C; Gearry RB; Wark G; Ghaly S; Begun M; Krishnaprasad K; Wu T; Ruddick-Collins L; Schreiber V; Okano S; Radford-Smith G; Schulberg J; van Langenberg D; Begun J, 2024, 'High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease', GastroHep, 2024, http://dx.doi.org/10.1155/2024/3686618

De Gregorio M; Winata LS-H; Hartley I; Behrenbruch CC; Connor SJ; D'Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJ; Schulberg JD; Srinivasan A; Sutherland T; Woods R; Wright EK; Connell W; Thompson A; Ding NS, 2024, 'Mo1817 IMPROVED CLINICAL AND RADIOLOGIC HEALING OF CROHN'S PERIANAL FISTULAS USING A NOVEL COORDINATED CARE MODEL OPTIMISING MEDICAL AND SURGICAL TREATMENTS: A PROSPECTIVE REAL-WORLD OBSERVATIONAL STUDY', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03056-7

Barnett MI; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1833 DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03072-5

McNamara J; Alshiwanna B; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135, http://dx.doi.org/10.1016/s0016-5085(24)03073-7

Alshiwanna B; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1835 DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135, http://dx.doi.org/10.1016/s0016-5085(24)03074-9

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 839, http://dx.doi.org/10.1016/s0016-5085(24)02405-3

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Su1874 THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)02438-7

Gu B; Pipicella JL; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'Tu1865 ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN ULCERATIVE COLITIS: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', Gastroenterology, 166, pp. S - 1444, http://dx.doi.org/10.1016/s0016-5085(24)03766-1

Pipicella JL; Gu B; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'Tu1866 ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN CROHN'S DISEASE: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03767-3

Pipicella JL; McNamara J; Wilson WE; Lynch KD; Walker GJ; Begun J; Lawrance IC; Ghaly S; Radford-Smith GL; Williams A-J; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03792-2

Pipicella JL; Vernon-Roberts A; Dutt S; Giles E; Day AS; Connor SJ; Andrews JM, 2023, 'Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease', Digestive Diseases and Sciences, 68, pp. 4368 - 4380, http://dx.doi.org/10.1007/s10620-023-08146-2

McNamara J; Connor SJ; Andrews JM, 2023, 'The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform', Inflammatory Bowel Diseases, 29, pp. 1510 - 1511, http://dx.doi.org/10.1093/ibd/izad148

Karimi N; Lukin A; Moore AR; Pipicella JL; Kanazaki R; Williams AJ; Ng W; Kariyawasam V; Mitrev N; Pandya K; Connor SJ, 2023, 'Adolescents and young adults communicating with gastroenterologists: Variation in inflammatory bowel disease clinical communication', International Journal of Adolescent Medicine and Health, 35, pp. 347 - 361, http://dx.doi.org/10.1515/ijamh-2023-0078

Kanazaki R; Smith B; Girgis A; Connor SJ, 2023, 'Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and Enablers', Crohn's and Colitis 360, 5, http://dx.doi.org/10.1093/crocol/otac018

Karimi N; Moore AR; Lukin A; Connor SJ, 2023, 'Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review', Crohn's and Colitis 360, 5, http://dx.doi.org/10.1093/crocol/otad021

Chan P; Connor S; Huang V; Karimi N; Williams AJ, 2023, 'Letter: expanding the role for decision aids in IBD into pregnancy-related topics', Alimentary Pharmacology and Therapeutics, 58, pp. 141 - 142, http://dx.doi.org/10.1111/apt.17545

Barnes A; Ooi SYJ; Lynch KD; Parthasarathy N; Bishara M; Gounder M; Grafton R; Leach P; Bampton P; Sechi A; Ng W; Connor S; van Langenberg D; Mountifield R; Andrews JM, 2023, 'Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease', Digestive Diseases and Sciences, 68, pp. 889 - 896, http://dx.doi.org/10.1007/s10620-022-07556-y

Louis E; Resche-Rigon M; Laharie D; Satsangi J; Ding N; Siegmund B; D'Haens G; Picon L; Bossuyt P; Vuitton L; Irving P; Viennot S; Lamb CA; Pollok R; Baert F; Nachury M; Fumery M; Gilletta C; Almer S; Ben-Horin S; Bouhnik Y; Colombel JF; Hertervig E; Andrews J; Sparrow M; Leong R; Connor S; Radforth-Smith G; De Cruz P; Preiss J; Stallmach A; Liceni T; Grip O; Halfvarson J; Durai D; Cummings F; Seilinger C; Parkes M; Lindsay J; Lambrecht G; Van Hootegem P; Rahier JF; Dewitte M; Hebuterne X; Chanteloup E; Altwegg R; Nancey S; Bouguen G; Pineton de Chambrun G; Poullenot F; Roblin X, 2023, 'Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial', The Lancet Gastroenterology and Hepatology, 8, pp. 215 - 227, http://dx.doi.org/10.1016/S2468-1253(22)00385-5

Mortlock S; Lord A; Montgomery G; Zakrzewski M; Simms LA; Krishnaprasad K; Hanigan K; Doecke JD; Walsh A; Lawrance IC; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow MP; Bell S; Florin TH; Begun J; Gearry RB; Radford-Smith GL, 2023, 'An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis', Journal of Crohn's and Colitis, 17, pp. 277 - 288, http://dx.doi.org/10.1093/ecco-jcc/jjac121

Mah C; Jayawardana T; Leong G; Koentgen S; Lemberg D; Connor SJ; Rokkas T; Grimm MC; Leach ST; Hold GL, 2023, 'Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review', Pathogens, 12, http://dx.doi.org/10.3390/pathogens12020262

Chan PPY; Farzin M; Acharya P; Viiala N; Gilmore A; Crane H; Henderson C; Ng W; Williams A; Connor SJ, 2023, 'Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis', ACG CASE REPORTS JOURNAL, 10, http://dx.doi.org/10.14309/crj.0000000000000978

Van Oostrom J; Anjie S; Braad M; Horrigan J; Karimi N; Adi B; Ganesh G; Yang SK; Lasa J; Broër C; de Kruif A; Olivera Sendra P; Ye BD; Banerjee R; Connor S; Siegel C; Peyrin-Biroulet L; Gecse K; D’Haens G, 2023, 'P185 Global perception of normal life by healthcare professionals and IBD patients: mind the gap', Journal of Crohn's and Colitis, 17, pp. i337 - i339, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0315

Back to profile page